Hdfc Pharma And Healthcare Fund Overview
Category Pharma Fund
BMSMONEY Rank N/A
BMSMONEY Rating N/A
Gro. Opt. As On: 19-11-2024
NAV ₹15.9(R) +1.07% ₹16.12(D) +1.07%
Returns 1Y 3Y 5Y 7Y 10Y
LumpSum (R) 50.25% -% -% -% -%
LumpSum (D) 52.14% -% -% -% -%
SIP (R) 26.02% -% -% -% -%
SIP (D) 27.66% -% -% -% -%
Ratio Sharpe Ratio Sortino Ratio Sterling Ratio Jensen's Alpha Treynor Ratio
Risk STD. Dev VaR 1Y95% Max DD Beta Semi Devi.
Top Pharma Fund
Fund Name Rank Rating
Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund -
Sbi Healthcare Opportunities Fund -
Tata India Pharma & Healthcare Fund -
Dsp Healthcare Fund -
Uti Healthcare Fund -

NAV Date: 19-11-2024

Scheme Name NAV Rupee Change Percent Change
HDFC Pharma and Healthcare Fund - IDCW Option 15.9
0.1700
1.0700%
HDFC Pharma and Healthcare Fund - Growth Option 15.9
0.1700
1.0700%
HDFC Pharma and Healthcare Fund - IDCW Option - Direct Plan 16.12
0.1700
1.0700%
HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan 16.12
0.1700
1.0700%

Review Date: 19-11-2024

A review of the different performance parameters of the fund is as follows:
  1. Returns: It reflects the surge in the investment's value throughout the investment period, communicated as a percentage or a specific monetary sum. Our analysis encompassed four return parameters of this fund. We have organized the return parameters into three performance groups for evaluation: the top 25%, parameters that rank below the top 25% but above average, and parameters that are below average. Below, you'll find a breakdown of how each parameter has performed.
    1. Top 25%: Four return parameters of the HDFC Pharma And Healthcare Fund are in the top 25% in the category, as shown below:
      • 1M Return %
      • 3M Return %
      • 6M Return %
      • 1Y Return %
    2. Above Average Below the Top 25%: The fund does not have any return parameter which is above average but below the top 25%.
    3. Below Average: HDFC Pharma And Healthcare Fund has no return parameters that are below average in the category.
  2. Risk: Various factors can lead to the risk of either not meeting expected returns or encountering a monetary loss. For HDFC Pharma And Healthcare Fund, we have analyzed zero risk parameters and divided them into three groups the lowest 25%, below average but above the lowest 25%, and above average, which are described below.
    1. Lowest 25%: HDFC Pharma And Healthcare Fund does not have any risk parameters in the lowest 25% of the category. It means high risk compared to other funds in the category.
    2. Below Average but Above the Lowest 25%: HDFC Pharma And Healthcare Fund does not have any risk parameters in the below average but above the lowest 25% of the category.
    3. Above Average: HDFC Pharma And Healthcare Fund does not have any risk parameters above average; which is a good sign.
  3. Risk Adjusted Performance Parameters: In mutual funds, risk-adjusted performance parameters are evaluation tools that gauge the returns of an investment against the risk taken. They assist investors in comparing various investments, factoring in both risk and returns. We have evaluated zero risk-adjusted performance parameters of the fund.
    1. Top 25% Risk Adjusted Performance Parameters: The fund does not have any risk-adjusted performance parameters that are in the top 25% of the category.
    2. Above Average Below Top 25% Risk Adjusted Performance Parameters: The fund does not have any risk-adjusted performance parameters that are in the above average but below top 25% of the category.
    3. Below Average Risk Adjusted Performance Parameters: The fund does not have any risk-adjusted performance parameters that are in the above average but below top 25% of the category.


Not able to see in mobile!!! save the chart by clicking on camera icon.

KPIs* Fund Benchmark Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % -1.60
-3.29
-6.13 | -1.38 3 | 13 Very Good
3M Return % 5.45
1.96
-4.87 | 6.68 3 | 13 Very Good
6M Return % 24.59
18.30
11.91 | 24.73 2 | 13 Very Good
1Y Return % 50.25
42.10
34.98 | 50.25 1 | 11 Very Good
1Y SIP Return % 26.02
11.42
-16.11 | 26.02 1 | 11 Very Good
Return data last Updated On : Nov. 19, 2024.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Oct. 31, 2024
KPIs: Key Performance Indicators

Rotate the phone! Best viewed in landscape mode on mobile.
KPIs* Fund Benchmark Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % -1.50 -3.19 -6.01 | -1.30 3 | 13
3M Return % 5.77 2.29 -4.48 | 7.04 3 | 13
6M Return % 25.36 19.06 12.84 | 25.80 2 | 13
1Y Return % 52.14 43.86 36.19 | 52.14 1 | 11
1Y SIP Return % 27.66 12.87 -14.86 | 27.66 1 | 11
Return data last Updated On : Nov. 19, 2024.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Oct. 31, 2024
KPIs: Key Performance Indicators

Investment Period Regular Direct
Return % Current Value of ₹ 10000 Return % Current Value of ₹ 10000
1D 1.07 ₹ 10,107.00 1.07 ₹ 10,107.00
1W -1.13 ₹ 9,887.00 -1.10 ₹ 9,890.00
1M -1.60 ₹ 9,840.00 -1.50 ₹ 9,850.00
3M 5.45 ₹ 10,545.00 5.77 ₹ 10,577.00
6M 24.59 ₹ 12,459.00 25.36 ₹ 12,536.00
1Y 50.25 ₹ 15,025.00 52.14 ₹ 15,214.00
3Y ₹ ₹
5Y ₹ ₹
7Y ₹ ₹
10Y ₹ ₹
15Y ₹ ₹

Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.

Investment Period Invested Amount Regular Direct
XIRR % Current Value of Invested Amount XIRR % Current Value of Invested Amount
1Y ₹ 12000 26.02 ₹ 13,637.21 27.66 ₹ 13,737.12
3Y ₹ 36000 ₹ ₹
5Y ₹ 60000 ₹ ₹
7Y ₹ 84000 ₹ ₹
10Y ₹ 120000 ₹ ₹
15Y ₹ 180000 ₹ ₹


Date Hdfc Pharma And Healthcare Fund NAV Regular Growth Hdfc Pharma And Healthcare Fund NAV Direct Growth
19-11-2024 15.899 16.122
18-11-2024 15.731 15.951
14-11-2024 15.861 16.081
13-11-2024 15.81 16.029
12-11-2024 16.08 16.302
11-11-2024 16.193 16.415
08-11-2024 16.384 16.607
07-11-2024 16.35 16.573
06-11-2024 16.568 16.793
05-11-2024 16.394 16.616
04-11-2024 16.297 16.517
31-10-2024 16.281 16.499
30-10-2024 15.957 16.17
29-10-2024 15.981 16.194
28-10-2024 16.038 16.251
25-10-2024 15.808 16.016
24-10-2024 15.893 16.102
23-10-2024 15.712 15.918
22-10-2024 15.833 16.04
21-10-2024 16.157 16.368

Fund Launch Date: 04/Oct/2023
Fund Category: Pharma Fund
Investment Objective: To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies.
Fund Description: An open-ended equity scheme investing in Pharma and healthcare companies
Fund Benchmark: BSE Healthcare Index
Source: Fund FactSheet

Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.